View Agent
| Agent Info | |
| Agent: | pazopanib |
| Synonyms: | Votrient (TN) |
| Drug Status For Certain Diseases: | Advanced renal cell carcinoma;Advanced soft tissue sarcoma(approved) |
| Classification: | a small molecule inhibitor of kinases principally including vascular endothelial growth factor receptors-1, -2, and -3;platelet-derived growth factor receptors-α and -β;and c-Kit |
| Target: | Platelet-derived growth factor receptor Mast/stem cell growth factor receptor Vascular endothelial growth factor receptor 2 |
| KEGG Pathway: | PI3K-Akt signaling pathway Endocytosis Central carbon metabolism in cancer Ras signaling pathway Cytokine-cytokine receptor interaction Rap1 signaling pathway Pathways in cancer VEGF signaling pathway Hematopoietic cell lineage Melanogenesis Acute myeloid leukemia |
| Wiki Pathway: | Kit receptor signaling pathway Nifedipine Activity miR-targeted genes in muscle cell - TarBase Focal Adhesion Differentiation Pathway miR-targeted genes in lymphocytes - TarBase Signaling by SCF-KIT PIP3 activates AKT signaling Cardiac Progenitor Differentiation miR-targeted genes in epithelium - TarBase Signaling by VEGF Angiogenesis |